Nalbuphine (HCl) Overview Categories 1 Drugs used in anesthesia1.3 preoperative medication and sedation 1 Drugs used in anesthesia1.5 Analgesics and opioid antagonists 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.2 Opioid analgesics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Alteplase Manufacturers of Alteplase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Alteplase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 10 to 20 mg15 (15)12 hourlyIM,IV,SCFor Pain. Frequency may be increased to 3 times if needed.0.3 to 3 mg/kg1.6 (1.65)As recommended.IVOver 10 to 15 minutes at induction , Maintanance doses of 250-500ug/kg may be given as intravanous bolus if required . Paedriatic Dosage (20kg) 0.1 to 0.15 mg/kg0.12 (0.125)6 hourlyIntra Muscular-0.1 to 0.15 mg/kg0.12 (0.125)6 hourlyIntra Venous-0.1 to 0.15 mg/kg0.12 (0.125)6 hourlySubcutaneous- Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Alteplase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Alteplase Back to top Manufacturers of Nalbuphine (HCl) in Pakistan Akhai Brookes Dosaco Elite Fynk Global GSK Healthtek ISIS Mass Medicaids Mediceena Medicraft Meezab Int. Neutro PDH Sami Siza Standpharm Swan Venus Back to top Previous Drug Generic - Next Drug Generic
Nalbuphine (HCl) Overview Categories 1 Drugs used in anesthesia1.3 preoperative medication and sedation 1 Drugs used in anesthesia1.5 Analgesics and opioid antagonists 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.2 Opioid analgesics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Alteplase Manufacturers of Alteplase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Alteplase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 10 to 20 mg15 (15)12 hourlyIM,IV,SCFor Pain. Frequency may be increased to 3 times if needed.0.3 to 3 mg/kg1.6 (1.65)As recommended.IVOver 10 to 15 minutes at induction , Maintanance doses of 250-500ug/kg may be given as intravanous bolus if required . Paedriatic Dosage (20kg) 0.1 to 0.15 mg/kg0.12 (0.125)6 hourlyIntra Muscular-0.1 to 0.15 mg/kg0.12 (0.125)6 hourlyIntra Venous-0.1 to 0.15 mg/kg0.12 (0.125)6 hourlySubcutaneous- Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Alteplase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Alteplase Back to top Manufacturers of Nalbuphine (HCl) in Pakistan Akhai Brookes Dosaco Elite Fynk Global GSK Healthtek ISIS Mass Medicaids Mediceena Medicraft Meezab Int. Neutro PDH Sami Siza Standpharm Swan Venus Back to top Previous Drug Generic - Next Drug Generic